No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Cost-Benefit Analysis
-
Enzyme Replacement Therapy / economics
-
Fabry Disease / genetics*
-
Fabry Disease / pathology
-
Fabry Disease / therapy
-
Female
-
Humans
-
Male
-
Mutation
-
alpha-Galactosidase / genetics
Substances
-
GLA protein, human
-
alpha-Galactosidase